Hepatobiliary Surgery and Nutrition

Papers
(The TQCC of Hepatobiliary Surgery and Nutrition is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Ascites and complications: getting to the root of the trouble105
Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?74
Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma71
Right or left hepatectomy: a continuing question in the era of pure laparoscopic donor hepatectomy54
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?49
Advocating for the implementation of SonoVue microbubbles as pressure sensors: a call to action for clinical noninvasive pressure estimation43
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation41
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy34
Future directions based on evaluation of long-term efficacy of total pancreatectomy and autologous islet transplantation30
Surveillance of non-resected branch-duct intraductal papillary mucinous neoplasms: is a simplified algorithm justified?30
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach29
The gut-liver axis links the associations between serum carotenoids and non-alcoholic fatty liver in a 7.8-year prospective study29
Where is the future of xenotransplantation headed?28
Non-invasive liver disease assessments: can they replace liver biopsy?28
Neoadjuvant therapy for resectable pancreatic cancers26
Sex and age differences in the association between obesity and long-term changes with the risk of incident type 2 diabetes mellitus: the Rural Deqing Cohort Study25
Emergent hybrid-dual-graft liver transplantation: a life-saving strategy for a patient with inadequate living donor graft during the COVID-19 pandemic22
Neuroendocrine liver metastases treatment strategies: a viewpoint18
3D laparoscopy and fluorescence imaging can improve surgical precision for hepatectomy18
The use of thermal ablation in the treatment of colorectal liver metastasis—proper selection and application of technology18
Cholangiocarcinoma: a review of the literature and future directions in therapy18
The difficulty of medical decision-making: should patients be involved?17
Does neoadjuvant therapy improve survival in pancreatic adenocarcinoma?17
Feasibility, safety and limits of robotic approach for lymphadenectomy in biliary tumours15
Choline suppresses hepatocellular carcinoma progression by attenuating AMPK/mTOR-mediated autophagy via choline transporter SLC5A7 activation15
Proposal of definition and diagnostic criteria for sarcopenic obesity by ESPEN and EASO15
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)14
The portal-umbilical-iliac-systemic venous shunt in liver cirrhosis13
Identification and treatment of biliary complications after liver transplantation: more relevant than ever13
Surgical treatment of colorectal cancer liver metastases: individualized comprehensive treatment makes a difference13
Peri-hospital care: time to have a system for arranging patient care before and after hospitalization13
Hepatic “pregnancy”: hepatocellular carcinoma with extensive extrahepatic growth12
More accurate reporting of surgical techniques would be SUPER12
Hepatic metastases in ovarian cancer12
Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer12
High volume transplant experience is beneficial but not mandatory for the performance of complex liver resections12
The ALPPS procedure—As Limited Procedures as Possible, leads to improved Survival11
International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma11
A Japanese multi-institutional randomized controlled trial (ND-Trial)11
Liver transplantation for non-resectable colorectal liver metastases10
Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?10
LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis10
Surgical decision-making: can patients benefit?10
Resection post-radio-embolization in patients with single large hepatocellular carcinoma9
Treatment of portal vein thrombosis in cirrhosis with anticoagulation—more than meets the eye?9
Microbial influence on liver regeneration: understanding gut microbiota and hepatic recovery post partial hepatectomy9
Slowly filling the gaps in our approach to diet and nutrition in inflammatory bowel diseases9
Comparable results of surgical versus non-surgical management for patients with malignant bowel obstruction—a lesson from S1316 study9
Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma8
Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer8
Giant hepatic neuroendocrine tumor8
Global similarities: comparison of the Korean Liver Cancer Association chemoembolization guidelines for hepatocellular carcinoma to the National Comprehensive Cancer Network, American Association for 8
Evaluation of the economic impact of the robotic approach in major and postero-superior segment liver resections: a multicenter retrospective analysis8
AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons8
National impact and advantages of the robotic approach to liver surgery in the era of minimally invasive surgery7
Efficacy and challenges of combining transarterial chemoembolization with pembrolizumab in advanced hepatocellular carcinoma: insights from the PETAL study7
Pancreatectomy with concomitant portal vein resection in the current neoadjuvant era7
Xanthophyll β-cryptoxanthin treatment inhibits hepatic steatosis without altering vitamin A status in β-carotene 9',10'-oxygenase knockout mice7
Recurrence beyond Milan criteria following liver resection for early-stage hepatocellular carcinoma: incidence, prediction and implications for treatment selection7
Transplantation for colorectal liver metastases: lessons from TransMet and future challenges7
Prevalence and longitudinal effects on mortality associated with spectrum of alcohol intake in steatotic liver disease: a United States population study7
The efforts are worth the benefits for laparoscopic liver resection7
Loco-regional treatments of unresectable hepatocellular carcinoma: safety first7
New practice guidelines on risk stratification and management of portal hypertension: towards a personalized multidisciplinary approach7
Shifting paradigm of quality of life after pancreatoduodenectomy for pancreas cancer7
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers7
Hype and hope of hepatic arterial infusion for colorectal cancer7
Does laparoscopic resection for colorectal cancer liver metastasis have a long-term oncologic advantage?6
New insights on portal hypertension’s screening in people with cystic fibrosis6
The challenge of hepatic vein reconstruction in surgical oncology6
Radiofrequency ablation versus microwave ablation for colorectal liver metastases: long-term results of a retrospective cohort surgical experience6
Guidelines on cholangioscopy for indeterminate biliary strictures: one step closer to consensus6
Tailoring bacterial taxa for immune cell modulation6
Conversion therapy for advanced cholangiocarcinoma in the era of molecular targeted therapy and immune therapy6
Electroacupuncture in liver regeneration: a Chinese traditional medicine approach to enhancing liver regeneration6
Laparoscopic anatomical versus non-anatomical liver resection for hepatocellular carcinoma in the posterosuperior segments: a propensity score matched analysis6
Simultaneous resection of synchronous colorectal liver metastases: a promising alternative to staged resections6
Robotic pancreaticoduodenectomy after the learning curve—a new hope5
Enhanced recovery after liver transplantation—a prospective analysis focusing on quality assessment5
The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications5
The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution5
Liver cirrhosis and sarcopenia: a dreadful combination5
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology5
Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience5
Reply to: The letter to the editor “More details are needed about the use of multicenter propensity score matching analysis” by Feng et al.5
Is the exposure to liver transplantation worthwhile for trainees in liver surgery?5
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guide5
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma5
Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer5
Exocrine pancreatic insufficiency: more compromise than precision5
East meets West: what opportunities arise in comparing international guidelines for management of cirrhosis?5
A combined Cox and logistic model provides accurate predictive performance in estimation of time-dependent probabilities for recurrence of intrahepatic cholangiocarcinoma after resection5
Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?5
A new era for hepatocellular carcinoma5
The Japanese Clinical Practice Guidelines for intrahepatic cholangiocarcinoma: a comparison with Western guidelines5
Association of Pringle maneuver with postoperative recurrence and survival following hepatectomy for hepatocellular carcinoma: a multicenter propensity score and competing-risks regression analysis5
3D laparoscopic anatomical hepatectomy guided by 2D real-time indocyanine green fluorescence imaging for hepatocellular carcinoma5
Breast cancer liver metastasis: time to resection and criteria4
Gallbladder volvulus4
Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma—a multicenter propensity score matching analysis4
The global burden of fatty liver disease: the major impact of China4
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma4
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection4
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study4
Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer—the more the better?4
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations4
Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice4
Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT4
Sarcopenia and gender disparities in liver transplant waiting lists: evaluating predictive scores and delisting risks4
Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population4
Advances in 3D bioprinting technology for liver regeneration4
Clinical utility of non-invasive tests to predict clinical outcomes in non-alcoholic fatty liver disease4
Influence of immunosuppressive drugs on natural killer cells in therapeutic drug exposure in liver transplantation4
Insights into treatment for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium3
Determinants of prognosis in cirrhosis: a new outlook3
A 7-year-old girl with giant congenital biliary dilatation3
The significance of severe postoperative complications on liver regeneration3
Comment on: Failure to rescue in patients with distal pancreatectomy: a nationwide analysis of 10,632 patients3
A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact3
Comparative associations of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease with risk of incident chronic kidney disease: a cohort study3
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study3
Guidelines towards comprehensive care in acute pancreatitis3
Enhancing perioperative evaluation and abdominal drain in patients undergoing distal pancreatectomy3
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience3
Synchronous colorectal liver metastases: therapeutic considerations3
High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection3
Nab-paclitaxel plus tegafur gimeracil oteracil potassium capsule (S-1) as first-line treatment for advanced biliary tract adenocarcinoma: a phase 2 clinical trial3
NAFLD or MAFLD: the data behind the debate3
Simultaneous portohepatic vein embolization a radiological: a short cut to associating liver partition and portal vein ligation for staged hepatectomy?3
The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease3
Liver venous deprivation (LVD) before extended hepatectomy: a French multicentric retrospective cohort3
Multiple liver abscesses caused by Streptococcus intermedius3
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation3
Surgical resection of isolated pancreatic metastatic malignant melanoma3
Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations3
Pancreatic cancer screening in high-risk individuals with genetic susceptibility3
Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluation3
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice3
Preoperative assessment of liver function and perioperative management of posthepatectomy liver failure3
Hepatic tuberculosis3
Micro-invasive pancreaticoduodenectomy will be a promising treatment option for distal cholangiocarcinoma3
Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined3
Eat more natural dietary fiber and whole grains to minimize liver disease risk3
Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”3
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma3
New guidelines for screening, evaluation and management of hepatobiliary disease in cystic fibrosis3
Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients3
Enhancing diagnostic strategies for biliary strictures: an evolving landscape3
Erratum to classification of hepatic venous tumor thrombus in hepatocellular carcinoma: should it describe tumor status or predict patient survival?3
Acute coil migration in upper gastrointestinal bleeding3
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review3
Expert consensus on magnetic recanalization technique for biliary anastomotic strictures after liver transplantation3
Editorial on “Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a propensity score matching analysis”2
Long-term outcomes in patients with non-alcoholic fatty liver disease: further evidence that a multidisciplinary and patient-centred approach to treatment is needed2
Functional assessment of liver regeneration after major hepatectomy2
Systemic treatment of hepatocellular carcinoma: the times they are a-changin’2
Adult living-donor liver transplantation without simultaneous splenectomy2
Management of severe acute pancreatitis: all hands to the pump2
Neutrophil extracellular traps contribute to the development of hepatocellular carcinoma in NASH by promoting Treg differentiation2
Comment on: oncologic outcomes after robotic pancreatic resections are not inferior to open surgery2
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy2
Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients2
Comment on: “Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial”2
Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma2
Finding a role for cancer vaccines in pancreatic cancer: a model of resilience2
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma2
Optimizing endoscopic diagnosis of biliary strictures of undetermined etiology: a practical guide based on the new ASGE guidelines2
The association between sarcopenia and cirrhosis: a Mendelian randomization analysis2
Resmetirom for metabolic dysfunction-associated steatohepatitis: targeting hepatic and cardiovascular disease2
The current application of thermal ablation in colorectal liver metastasis2
The rate of muscle wasting in liver transplant recipients on waiting list: post-transplant outcomes and associated serum metabolite patterns2
The potential role of associating liver partition and portal vein ligation in the treatment of colorectal liver metastases2
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular 2
Comment on “Perihilar cholangiocarcinoma—novel benchmark values for surgical and oncological outcomes from 24 expert centers”2
The uprising of metabolic dysfunction-associated fatty liver disease (MAFLD) in acute-on-chronic liver failure (ACLF)2
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option2
The role of B cells in metabolic (dysfunction)-associated fatty liver disease2
Intrahepatic portal vein variant: a single dilated intrahepatic portal vein coursing to the umbilical fissure without second-order branches2
Same soup different taste—how to best manage the future liver remnant—a surgical perspective2
Comparison of alternative arterial anastomosis site during liver transplantation when the recipient’s hepatic artery is unusable2
Living donor liver transplantation combined with splenectomy in a child with Niemann-Pick disease type B: single-centre experience of perioperative anticoagulation regimen2
Beyond management to conquer life-threatening tumor thrombosis in hepatocellular carcinoma2
Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?2
Management of decompensated liver cirrhosis in the surgical intensive care unit2
Comment on “Hypothermic machine perfusion in liver transplantation—a randomized trial”2
Transforming liver surgery: the shift from traditional resections to minimally invasive and parenchymal-sparing techniques2
Modern surgical approach to hepatocellular carcinoma2
Total pancreatectomy with islet cell auto-transplantation for chronic pancreatitis: sustaining long-term glycemic health with or without graft function2
Pancreaticoduodenectomy: how to handle a replaced right hepatic artery2
The French guidelines for alcohol-related liver disease—what’s new, what’s not and what’s still needed2
Beneficial effect of whole-grain wheat on liver fat: a role for the gut microbiota?2
Optimizing management of patients with pancreatic exocrine insufficiency2
Integrative medicine and surgery: what are the diet and supplement recommendations for someone with pancreatic cancer?2
Liver transplantation for unresectable colorectal liver metastases (CRLM) using extended criteria donor (ECD) grafts: proceed with caution2
Surgical Infection Society guidelines on antibiotic use in gallstone surgery: high time we crack down on prophylactic antibiotics2
Shrinking fat, healing liver: unlocking the metabolic dysfunction associated steatohepatitis puzzle2
Are probiotics effective in reversing non-alcoholic steatohepatitis?2
Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases2
The power of prevention: how tenofovir and entecavir are changing the game in hepatocellular carcinoma2
Precision surgery with the genetic assessment for operable pancreatic cancer beyond the radiological assessment alone2
Surgical treatment strategies for multifocal hepatocellular carcinomas2
The microbiome as a potential diagnostic biomarker for pancreatic ductal adenocarcinoma (PDAC)2
Influence of skeletal muscle mass on graft regeneration after living-donor liver transplantation2
Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection2
Addressing the malnutrition gap requires high-quality research, recognition of intervention complexity, and equitable implementation strategies2
The need for deepened molecular mechanism exploration in new onset diabetes after transplantation (NODAT)2
Is liver resection necessary for T2 gallbladder cancer?2
Robotic hepatectomy: challenge and progression2
0.11522722244263